Bank of America’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-160,200
| Closed | -$13.6M | – | 7580 |
|
|
2019
Q4 | $13.6M | Sell |
160,200
-5,100
| -3% | -$340K | ﹤0.01% | 2245 |
|
|
2019
Q3 | $8.27M | Sell |
165,300
-146,700
| -47% | -$5.85M | ﹤0.01% | 2709 |
|
|
2019
Q2 | $11.4M | Buy |
312,000
+282,500
| +958% | +$9.22M | ﹤0.01% | 2405 |
|
|
2019
Q1 | $825K | Buy |
29,500
+20,000
| +211% | +$471K | ﹤0.01% | 4662 |
|
|
2018
Q4 | $182K | Hold |
9,500
| – | – | ﹤0.01% | 5582 |
|
|
2018
Q3 | $284K | Sell |
9,500
-151,100
| -94% | -$5.69M | ﹤0.01% | 5292 |
|
|
2018
Q2 | $5.89M | Buy |
+160,600
| New | +$5.22M | ﹤0.01% | 2992 |
|
|
2018
Q1 | – | Sell |
-42,600
| Closed | -$1.17M | – | 7460 |
|
|
2017
Q4 | $1.17M | Buy |
42,600
+20,000
| +88% | +$616K | ﹤0.01% | 4383 |
|
|
2017
Q3 | $837K | Sell |
22,600
-10,500
| -32% | -$387K | ﹤0.01% | 4629 |
|
|
2017
Q2 | $1.26M | Buy |
+33,100
| New | +$1.47M | ﹤0.01% | 4269 |
|
|
2017
Q1 | – | Sell |
-28,600
| Closed | -$971K | – | 7399 |
|
|
2016
Q4 | $971K | Buy |
28,600
+100
| +0.4% | +$3.55K | ﹤0.01% | 4365 |
|
|
2016
Q3 | $1.08M | Buy |
+28,500
| New | +$1.07M | ﹤0.01% | 4109 |
|
|
2016
Q2 | – | Sell |
-40,000
| Closed | -$1.27M | – | 7537 |
|
|
2016
Q1 | $1.27M | Buy |
+40,000
| New | +$1.31M | ﹤0.01% | 3935 |
|
|
2013
Q3 | – | Sell |
-30,000
| Closed | -$923K | – | 8123 |
|
|
2013
Q2 | $923K | Buy |
+30,000
| New | +$1M | ﹤0.01% | 4134 |
|
Other funds holding MDCO
Bank of America's MDCO Position: Q1 2020 in Review
Bank of America sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,220,832 shares — an estimated $104M sold.
Bank of America first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $104M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bank of America reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bank of America sold 1,220,832 Medicines Co shares in Q1 2020, an estimated $104M.
- Bank of America first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Bank of America's Medicines Co position peaked at $104M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bank of America's 13F filing for Q1 2020, filed 15 May 2020.